Literature DB >> 33509130

Thermographic follow-up of postherpetic neuralgia (PHN) subsequent to Ramsay Hunt syndrome with multicranial nerve (V, VII, VIII and IX) involvement: a case report.

Yuan-Mei Liao1, Hai-Feng Lu2, Peng Xie3, Ying Zhao4, Qiu Han5, Qian-Xi Zhang6, Xiao-Hua Zuo7,8, Yan-Na Si9, Hong-Guang Bao9.   

Abstract

BACKGROUND: Ramsay Hunt syndrome (RHS) is caused by a reactivation of varicella-zoster virus (VZV) infection, and it is characterized by the symptoms of facial paralysis, otalgia, auricular rash, and/or an oral lesion. Elderly patients or immunocompromised patients, deep pain at the initial visit and no prompt treatment are significant predictors of postherpetic neuralgia (PHN). When PHN occurs, especially involved cranial polyneuropathy, multiple modalities should be administered for patients with the intractable PHN. The use of thermography in the follow-up of PHN secondary to RHS with multicranial nerve involvement has not yet been described yet in the literature. CASE
PRESENTATION: The patient was a 78-year-old man with the chief complaint of a 3-month history of PHN secondary to RHS with polycranial nerve (V, VII, VIII, and IX) involvement. Multimodality therapy with oral gabapentin, pulsed radiofrequency (PRF) application to the Gasserian ganglion for pain in the trigeminal nerve region, linear-polarized near-infrared light irradiation for pain in the facial nerve region, and 2% lidocaine spray for pain in the glossopharyngeal nerve region was used to the treat patient, and follow-up evaluations included thermography. This comprehensive treatment obviously improved the quality of life, resulting in considerable pain relief, as indicated by a decrease in the numerical rating scale (NRS) score from 9 to 3 and a decrease in thermal imaging temperature from higher to average temperature on the ipsilateral side compared with the contralateral side. Lidocaine spray on the tonsillar branches of the glossopharyngeal nerve resulted in an improvement in odynophagia, and the NRS score decreased from 9 to 0 for glossopharyngeal neuralgia after three applications.
CONCLUSION: Although the use of thermography in the follow-up of RHS with multiple cranial nerve (V, VII, VIII, and IX) involvement is very rare, in this patient, thermal imaging showed the efficacy of combination therapy (oral gabapentin, 2% lidocaine sprayed, PRF application and linear-polarized near-infrared light irradiation) and that is a good option for treatment.

Entities:  

Keywords:  Infrared thermography; Linear-polarized near-infrared light; Multiple cranial nerves; Postherpetic neuralgia (PHN); Ramsay Hunt syndrome

Mesh:

Substances:

Year:  2021        PMID: 33509130      PMCID: PMC7840788          DOI: 10.1186/s12883-021-02071-5

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  17 in total

1.  Trigeminal herpes zoster and Ramsay Hunt syndrome with a lesion in the spinal trigeminal nucleus and tract.

Authors:  Chia-Wei Hung; Shuu-Jiun Wang; Shih-Pin Chen; Jiing-Feng Lirng; Jong-Ling Fuh
Journal:  J Neurol       Date:  2010-02-13       Impact factor: 4.849

2.  Herpes zoster oticus: a clinical model for a transynaptic, reflex pathways, viral transmission hypotheses.

Authors:  Matteo Alicandri-Ciufelli; Elisa Aggazzotti-Cavazza; Elisabetta Genovese; Daniele Monzani; Livio Presutti
Journal:  Neurosci Res       Date:  2012-06-16       Impact factor: 3.304

3.  Analgesic efficacy and safety of medical therapy alone vs combined medical therapy and extraoral glossopharyngeal nerve block in glossopharyngeal neuralgia.

Authors:  Preet M Singh; Maya Dehran; Virender K Mohan; Anjan Trikha; Manpreet Kaur
Journal:  Pain Med       Date:  2012-12-28       Impact factor: 3.750

4.  Bupivacaine inhibits activation of neuronal spinal extracellular receptor-activated kinase through selective effects on ionotropic receptors.

Authors:  Fumi Yanagidate; Gary R Strichartz
Journal:  Anesthesiology       Date:  2006-04       Impact factor: 7.892

5.  Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.

Authors:  John A Robbins; Aaron Aragaki; Carolyn J Crandall; JoAnn E Manson; Laura Carbone; Rebecca Jackson; Cora Elizabeth Lewis; Karen C Johnson; Gloria Sarto; Marcia L Stefanick; Jean Wactawski-Wende
Journal:  Menopause       Date:  2014-02       Impact factor: 2.953

6.  Non-surgical therapy for bilateral glossopharyngeal neuralgia caused by Eagle's syndrome, diagnosed by three-dimensional computed tomography: a case report.

Authors:  Masanori Kawasaki; Sunao Hatashima; Tomio Matsuda
Journal:  J Anesth       Date:  2012-07-04       Impact factor: 2.078

7.  Effects of Linearly Polarized Near-Infrared Irradiation Near the Stellate Ganglion Region on Pain and Heart Rate Variability in Patients with Neuropathic Pain.

Authors:  Chun-De Liao; Chi-Lun Rau; Tsan-Hon Liou; Jau-Yih Tsauo; Li-Fong Lin
Journal:  Pain Med       Date:  2017-03-01       Impact factor: 3.750

8.  The α2δ-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic Actions.

Authors:  Jinjun Chen; Lingyong Li; Shao-Rui Chen; Hong Chen; Jing-Dun Xie; Rita E Sirrieh; David M MacLean; Yuhao Zhang; Meng-Hua Zhou; Vasanthi Jayaraman; Hui-Lin Pan
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

9.  Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial.

Authors:  Dan Li; Guohua Sun; Hanzhe Sun; Yanjuan Wang; Zhiping Wang; Jianping Yang
Journal:  PeerJ       Date:  2018-06-04       Impact factor: 2.984

10.  Ramsay Hunt Syndrome with Multiple Cranial Neuropathy in an Human Immunodeficiency Virus (HIV) Patient.

Authors:  Divya Arya; Tushar Bajaj; Jose Gonzalez; Rene Elkin
Journal:  Am J Case Rep       Date:  2018-01-18
View more
  1 in total

1.  Facial Paralysis Detection in Infrared Thermal Images Using Asymmetry Analysis of Temperature and Texture Features.

Authors:  Xulong Liu; Yanli Wang; Jingmin Luan
Journal:  Diagnostics (Basel)       Date:  2021-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.